Alison M. Kell

1.5k total citations
22 papers, 1.1k citations indexed

About

Alison M. Kell is a scholar working on Immunology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Alison M. Kell has authored 22 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 10 papers in Infectious Diseases and 5 papers in Molecular Biology. Recurrent topics in Alison M. Kell's work include Viral Infections and Vectors (9 papers), interferon and immune responses (7 papers) and Mosquito-borne diseases and control (4 papers). Alison M. Kell is often cited by papers focused on Viral Infections and Vectors (9 papers), interferon and immune responses (7 papers) and Mosquito-borne diseases and control (4 papers). Alison M. Kell collaborates with scholars based in United States, United Kingdom and Italy. Alison M. Kell's co-authors include Michael Gale, Shane L. Rea, Thomas Johnson, Natascia Ventura, Thomas E. Johnson, Johannes Schwerk, Ram Savan, Gael Kurath, Andrew R. Wargo and David G. Whitten and has published in prestigious journals such as Nature Medicine, The Journal of Experimental Medicine and Nature Immunology.

In The Last Decade

Alison M. Kell

20 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alison M. Kell United States 15 443 401 247 182 173 22 1.1k
Masako Tanabe Japan 19 798 1.8× 1.1k 2.7× 123 0.5× 117 0.6× 193 1.1× 21 1.9k
Margery Smelkinson United States 21 666 1.5× 642 1.6× 132 0.5× 218 1.2× 296 1.7× 37 1.8k
Mark S. Rutherford United States 18 354 0.8× 254 0.6× 286 1.2× 38 0.2× 97 0.6× 47 1.2k
Ann Schlesinger United States 6 451 1.0× 638 1.6× 151 0.6× 301 1.7× 184 1.1× 6 1.3k
Krishnamurthy Malathi United States 20 844 1.9× 839 2.1× 189 0.8× 15 0.1× 256 1.5× 29 1.6k
Ricardo Madrid Spain 19 176 0.4× 615 1.5× 167 0.7× 11 0.1× 110 0.6× 33 1.2k
Zuyong He China 21 80 0.2× 810 2.0× 175 0.7× 28 0.2× 74 0.4× 77 1.4k
Youn Jung Choi South Korea 12 457 1.0× 387 1.0× 184 0.7× 7 0.0× 286 1.7× 47 1.0k
J. Greenwood United States 18 211 0.5× 572 1.4× 66 0.3× 30 0.2× 112 0.6× 34 1.1k
Kenneth J. Blank United States 17 597 1.3× 228 0.6× 140 0.6× 17 0.1× 172 1.0× 59 1.0k

Countries citing papers authored by Alison M. Kell

Since Specialization
Citations

This map shows the geographic impact of Alison M. Kell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison M. Kell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison M. Kell more than expected).

Fields of papers citing papers by Alison M. Kell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison M. Kell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison M. Kell. The network helps show where Alison M. Kell may publish in the future.

Co-authorship network of co-authors of Alison M. Kell

This figure shows the co-authorship network connecting the top 25 collaborators of Alison M. Kell. A scholar is included among the top collaborators of Alison M. Kell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison M. Kell. Alison M. Kell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Klimaj, Stefan D., et al.. (2024). Seoul orthohantavirus evades innate immune activation by reservoir endothelial cells. PLoS Pathogens. 20(11). e1012728–e1012728.
2.
Gale, Michael, et al.. (2023). Orthohantavirus Replication in the Context of Innate Immunity. Viruses. 15(5). 1130–1130.
3.
Kaya, Kemal, Mohammed I. Khalil, Pradeepkumar Jagadesan, et al.. (2022). Rapid and Effective Inactivation of SARS-CoV-2 with a Cationic Conjugated Oligomer with Visible Light: Studies of Antiviral Activity in Solutions and on Supports. ACS Applied Materials & Interfaces. 14(4). 4892–4898. 11 indexed citations
4.
Zhang, Zhen, David G. Whitten, & Alison M. Kell. (2022). Fluorescent Cellulose Wipe as a New and Sustainable Light-Activated Antibacterial and Antiviral Agent. ACS Materials Letters. 4(2). 356–362. 10 indexed citations
5.
Simons, Peter C., et al.. (2021). Integrin activation is an essential component of SARS-CoV-2 infection. Scientific Reports. 11(1). 20398–20398. 48 indexed citations
6.
Kell, Alison M.. (2021). Innate Immunity to Orthohantaviruses: Could Divergent Immune Interactions Explain Host-specific Disease Outcomes?. Journal of Molecular Biology. 434(6). 167230–167230. 4 indexed citations
7.
Perkins, Douglas J., et al.. (2020). COVID-19 global pandemic planning: Dry heat incubation and ambient temperature fail to consistently inactivate SARS-CoV-2 on N95 respirators. Experimental Biology and Medicine. 246(8). 952–959. 4 indexed citations
8.
Saha, Bhaskar, et al.. (2020). A non-canonical role for the autophagy machinery in anti-retroviral signaling mediated by TRIM5α. PLoS Pathogens. 16(10). e1009017–e1009017. 13 indexed citations
9.
Kell, Alison M., Emily A. Hemann, Julie Turnbull, & Michael Gale. (2020). RIG-I-like receptor activation drives type I IFN and antiviral signaling to limit Hantaan orthohantavirus replication. PLoS Pathogens. 16(4). e1008483–e1008483. 27 indexed citations
10.
Jagadesan, Pradeepkumar, Patrick L. Donabedian, Linnea K. Ista, et al.. (2020). Highly Effective Inactivation of SARS-CoV-2 by Conjugated Polymers and Oligomers. ACS Applied Materials & Interfaces. 12(50). 55688–55695. 46 indexed citations
11.
Schwerk, Johannes, Frank Soveg, Kerri R. Thomas, et al.. (2019). RNA-binding protein isoforms ZAP-S and ZAP-L have distinct antiviral and immune resolution functions. Nature Immunology. 20(12). 1610–1620. 91 indexed citations
12.
Schwerk, Johannes, Chrissie Lim, Alison M. Kell, et al.. (2016). Interferon lambda 4 expression is suppressed by the host during viral infection. The Journal of Experimental Medicine. 213(12). 2539–2552. 49 indexed citations
13.
Jarret, Abigail, Adelle P. McFarland, Stacy M. Horner, et al.. (2016). Hepatitis-C-virus-induced microRNAs dampen interferon-mediated antiviral signaling. Nature Medicine. 22(12). 1475–1481. 41 indexed citations
14.
Kell, Alison M. & Michael Gale. (2015). RIG-I in RNA virus recognition. Virology. 479-480. 110–121. 345 indexed citations
15.
Kell, Alison M., et al.. (2015). Pathogen-Associated Molecular Pattern Recognition of Hepatitis C Virus Transmitted/Founder Variants by RIG-I Is Dependent on U-Core Length. Journal of Virology. 89(21). 11056–11068. 25 indexed citations
16.
Kell, Alison M., Andrew R. Wargo, & Gael Kurath. (2014). Viral fitness does not correlate with three genotype displacement events involving infectious hematopoietic necrosis virus. Virology. 464-465. 146–155. 16 indexed citations
17.
Kell, Alison M., Andrew R. Wargo, & Gael Kurath. (2013). The Role of Virulence in In Vivo Superinfection Fitness of the Vertebrate RNA Virus Infectious Hematopoietic Necrosis Virus. Journal of Virology. 87(14). 8145–8157. 16 indexed citations
18.
Schiavi, Alfonso, Alessandro Torgovnick, Alison M. Kell, et al.. (2012). Autophagy induction extends lifespan and reduces lipid content in response to frataxin silencing in C. elegans. Experimental Gerontology. 48(2). 191–201. 50 indexed citations
19.
Wargo, Andrew R., et al.. (2012). Analysis of host genetic diversity and viral entry as sources of between-host variation in viral load. Virus Research. 165(1). 71–80. 14 indexed citations
20.
Kell, Alison M., et al.. (2007). Activation of SKN-1 by novel kinases in Caenorhabditis elegans. Free Radical Biology and Medicine. 43(11). 1560–1566. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masako Tanabe Breakdown of academic impact, for papers by Margery Smelkinson Breakdown of academic impact, for papers by Mark S. Rutherford Breakdown of academic impact, for papers by Ann Schlesinger Breakdown of academic impact, for papers by Krishnamurthy Malathi Breakdown of academic impact, for papers by Ricardo Madrid Breakdown of academic impact, for papers by Zuyong He Breakdown of academic impact, for papers by Youn Jung Choi Breakdown of academic impact, for papers by J. Greenwood Breakdown of academic impact, for papers by Kenneth J. Blank
Rankless by CCL
2026